NR-AXSPA

Clinical trials for NR-AXSPA explained in plain language.

Never miss a new study

Get alerted when new NR-AXSPA trials appear

Sign up with your email to follow new studies for NR-AXSPA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1

New drug shows promise for Long-Term control of back pain condition

Disease control Ongoing

This study is testing the long-term safety and effectiveness of bimekizumab, a drug that reduces inflammation, in 508 adults with active axial spondyloarthritis (including ankylosing spondylitis). Participants who completed earlier trials will receive the drug for an extended per…

Matched conditions: NR-AXSPA

Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control

Last updated Jun 27, 2026 12:36 UTC

NR-AXSPA

Get alerted when new NR-AXSPA trials appear

New drug shows promise for Long-Term control of back pain condition